Scientific Prestige at a Premium: China Redirects Research Funding Away from Costly Western Journals

• Chinese Academy of Sciences banned using government funds for expensive Western journals like Cell Reports and Nature Communications

• Publication fees reach US$7,350 per article, compared to global US$2,000 average

• China spends tens of millions annually on Western publishers

• Ban excludes flagship journals like Nature and Science

• Policy aims to strengthen domestic scientific publishing and reduce foreign expenditure

In a significant policy shift, China's premier scientific institution has implemented new restrictions on how government research funds can be spent on academic publishing. The Chinese Academy of Sciences (CAS) recently informed its researchers they can no longer use central government funding to cover publication fees in several expensive Western scientific journals, marking a recalibration of China's approach to international academic visibility.

Just before the Chinese New Year celebrations began, scientists across CAS received notification of updated publication guidelines that specifically target high-cost open access journals. "For high-fee journals such as Cell Reports, Nature Communications and Science Advances, central government funds may not be used to reimburse article processing charges," stated an email from a Beijing-based CAS institute's science and technology office dated February 13.

The policy aims to "optimize management of academic publishing, reasonably control article processing charge expenditure and improve the efficiency of research fund use," according to the communication.

Open access publishing, which requires authors to pay upfront fees to make their research freely available online, has become increasingly prevalent alongside traditional subscription models where readers or institutions pay for access. However, the fees charged by prestigious Western journals significantly exceed global averages.

Nature Communications, published by Europe-based Springer Nature, demands $7,350 per article, while Science Advances, from the American Association for the Advancement of Science, charges $5,450. These rates far surpass the approximately $2,000 global average and even China's own high-impact National Science Review, which charges around $2,100.

The financial implications are substantial. Last year alone, Nature Communications published over 10,000 papers, with Chinese researchers contributing at least a quarter of this output. For this single journal, Chinese government funding flowing to a Western publisher amounts to tens of millions of dollars annually.

This policy change has created dilemmas for Chinese scientists with papers currently under review at these journals. One CAS researcher, speaking anonymously, described facing a difficult decision with a manuscript at Science Advances: either withdraw and resubmit elsewhere—requiring substantial revisions—or personally cover the publication fee from their own salary.

While theoretically non-government funding could be used, this presents challenges for many researchers. "We do basic science, and we never have private grants," the scientist explained.

Ross Mitchell, an American geologist working at CAS's Institute of Geology and Geophysics, acknowledged potential short-term difficulties, particularly for early-career scientists. "These journals are very important, and publishing in them brings significant career benefits," he noted. However, he suggested long-term advantages: "This move could help China build its own competitive interdisciplinary journals, which is essential for becoming a true research powerhouse."

The policy reflects growing concerns about the economics of academic publishing. Critics have long argued that taxpayers effectively pay twice—first funding the research itself, then again through either subscription fees or publication charges to access results. Most of the intellectual labor, including writing, peer review, and editing, comes from publicly funded researchers who typically receive no additional compensation, while commercial publishers collect the majority of revenue.

Mitchell characterized academic publishing as "one of the most capitalistic ventures," noting China has historically prioritized producing research rather than developing platforms to distribute it.

Interestingly, the most prestigious journals like Nature, Science, and Cell aren't included in the ban. CAS researchers can still use government grants to pay up to $12,690 for open access publication in Nature, or publish in the traditional subscription format at no cost.

"It's an interesting compromise," Mitchell observed. "They do not want to stop people from trying to publish in the top, top journals like Science and Nature, even though they cost a lot more money." The policy primarily targets expensive open-access-only journals, particularly spin-offs from major scientific brands.

Mitchell remains optimistic, suggesting this approach could ultimately strengthen China's own scientific publishing ecosystem. "The truth is, China needs journals like these," he said, expressing hope the policy would incentivize development of domestic alternatives.